Literature DB >> 2159190

Hepatic resection for hepatocellular carcinoma.

T Tsuzuki1, A Sugioka, M Ueda, S Iida, T Kanai, H Yoshii, K Nakayasu.   

Abstract

Between July 1973 and September 1988, 119 patients with hepatocellular carcinoma underwent hepatic resection at Keio University Hospital, Tokyo. Hepatic resection was performed not only for patients with liver cirrhosis and obstructive jaundice but also for patients with advanced disease. Eighty (67.2%) of the 119 patients had liver cirrhosis and four patients had obstructive jaundice. Two or more segments of the liver were resected in 56 (47.0%) patients, 29 of whom had liver cirrhosis. Eleven patients died within 30 days after surgery, an operative mortality rate of 9.2%. Seven additional patients could not be discharged from the hospital, resulting in a hospital death rate of 5.9%. Seventeen of these 18 patients had cirrhosis. Selection of patients with sufficient reserve function of the remaining liver portion, caused a great reduction of the incidence of postoperative death. The 5-year actuarial survival rate for the 101 patients who were discharged from the hospital was 39%, and 13 patients lived longer than 5 years, the longest survival period being 13 years 10 months. Hepatocellular carcinoma is amenable to hepatic resection if patients with sufficient reserve function of the liver are selected.

Entities:  

Mesh:

Year:  1990        PMID: 2159190

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  34 in total

Review 1.  Therapeutic management algorithm in cirrhotic and noncirrhotic patients in primary or secondary liver masses.

Authors:  Eldo Ermenegildo Frezza
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

2.  Parenchymal transection with ultrasonic scalpel in liver resection.

Authors:  O Abbasoglu; I Sayek
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

3.  Role of computed tomographic arterial portography and intraoperative ultrasound in the evaluation of patients for resectability of hepatic lesions.

Authors:  R C Karl; J Choi; T J Yeatman; R A Clark
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

Review 4.  Biological treatment for liver tumor and new potential biomarkers.

Authors:  Maurizio Chiriva-Internati; Fabio Grizzi; Mitchell S Wachtel; Marjorie Jenkins; Raffaele Ferrari; Everardo Cobos; Eldo E Frezza
Journal:  Dig Dis Sci       Date:  2007-08-22       Impact factor: 3.199

5.  The pathological basis of resection margin for hepatocellular carcinoma.

Authors:  E C Lai; K T You; I O Ng; T W Shek
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

Review 6.  Radiofrequency thermal ablation of hepatocellular carcinomas.

Authors:  H K Lim
Journal:  Korean J Radiol       Date:  2000 Oct-Dec       Impact factor: 3.500

7.  Helical tomotherapy for single and multiple liver tumours.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Fu-Min Fang; Te-Jen Su; Stephen W Leung; Hsuan-Chih Hsu
Journal:  Radiat Oncol       Date:  2010-06-24       Impact factor: 3.481

8.  Operative results in 143 patients with hepatocellular carcinoma.

Authors:  T Segawa; R Tsuchiya; J Furui; K Izawa; T Tsunoda; T Kanematsu
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

9.  Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions.

Authors:  M Monden; M Sakon; M Gotoh; T Kanai; K Umeshita; K S Wang; M Sakurai; C Kuroda; J Okamura; T Mori
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Hepatic resection for hepatocellular carcinoma.

Authors:  M Suenaga; A Nakao; A Harada; T Nonami; Y Okada; H Sugiura; S Uehara; H Takagi
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.